News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.
chromosomes and dna

Five Prime Therapeutics Presents Data from Safety Lead-in to Phase 3 FIGHT Trial of Bemarituzumab at 2019 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium

“Gastric cancer with FGFR2b overexpression or FGFR2 gene amplification is associated with a poor prognosis for patients with advanced disease,” said Helen Collins, M.D., senior vice president and chief medical officer of Five Prime of MacroGenics of new research presented at the 2019 ASCO Gastrointestinal Cancers Symposium.

Read Source